Clinical Trial Update: Impact of Hemodialysis on Exhaled Volatile Organic Compounds in End Stage Renal Disease

View source ↗

Summary

A completed clinical trial investigating how hemodialysis affects exhaled volatile organic compounds in patients with End Stage Renal Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: Rambam Health Care Campus | Conditions: End Stage Renal Disease | Status: COMPLETED